Umesh Sandu 's most recent trade in Sandu Pharmaceuticals Ltd. was a Acquisition of 236,500 Equity Shares done at an average price of Rs. 20.7 . Disclosure was reported to the exchange on July 16, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Umesh Sandu 's has made SAST transactions in Sandu Pharmaceuticals Ltd. recently where a Acquisition of 619,996 shares done . Disclosure was reported to the exchange on July 16, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandu Pharma | Umesh Sandu & Others | Promoter | Acquisition | 18 Jul 2022 | 619,996 | 5,063,633 (52.42%) | 6.42% | - | 14 Jul 2022 14 Jul 2022 |
SAST (29(2)) | - | Conv. of Warrants | |
| Sandu Pharma | UMESH B SANDU | Promoter & Director | Acquisition | 16 Jul 2022 | 236,500 | 1,388,693 (14.37%) | 2.68% | 20.7 | 4,893,185 | 14 Jul 2022 14 Jul 2022 |
Insider Trading | Equity Shares | Allotment |
| Sandu Pharma | Umesh Sandu & PACs | Promoter | Acquisition | 04 Mar 2022 | 639,667 | 4,443,637 (50.43%) | 8.08% | - | 02 Mar 2022 02 Mar 2022 |
SAST (29(2)) | - | Preferential Basis | |
| Sandu Pharma | UMESH B SANDU | Promoter & Director | Acquisition | 04 Mar 2022 | 236,500 | 1,152,193 (13.08%) | 2.99% | 20.7 | 4,893,185 | 02 Mar 2022 02 Mar 2022 |
Insider Trading | Equity Shares | Allotment |
| Sandu Pharma | Umesh B Sandu & PAC | Promoter | Acquisition | 06 Apr 2021 | 614,832 | 3,767,970 (48.02%) | 7.76% | - | 31 Mar 2021 31 Mar 2021 |
SAST (29(2)) | - | Pref. Allotment | |
| Sandu Pharma | UMESH B SANDU | Promoter & Director | Acquisition | 03 Apr 2021 | 236,500 | 915,693 (11.56%) | 3.34% | 20.7 | 4,893,185 | 31 Mar 2021 31 Mar 2021 |
Insider Trading | Equity Shares | Allotment |
| Sandu Pharma | Umesh Sandu & Others | Promoter | Acquisition | 02 Apr 2021 | 1,874,495 | 1,377,135 (19.45%) | 26.47% | - | 30 Mar 2021 30 Mar 2021 |
SAST (29(2)) | - | Preferential Allotment (conversion Of Warrants Into Equity Share) | |
| Sandu Pharma | UMESH B SANDU | Promoter & Director | Acquisition | 01 Apr 2021 | 709,500 | 1,388,693 (14.37%) | 10.02% | 20.7 | 14,679,555 | 30 Mar 2021 30 Mar 2021 |
Insider Trading | Warrants | Allotment |